Halozyme Therapeutics | Nakit Ve Eşdeğer





Nakit Ve Eşdeğer Değişiklik Tarih
Acadia Pharmaceuticals USD 847.02M 85.02M 2025-09
Agios Pharmaceuticals USD 92.71M 11.84M 2025-09
Alnylam Pharmaceuticals USD 1.49B 376.56M 2025-09
Amarin USD 122.8M 25.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Baxter International USD 1.73B 40M 2025-09
Cara Therapeutics USD 20.65M 13.57M 2025-06
Cytokinetics USD 225.47M 150.53M 2025-09
DBV Technologies USD 69.84M 33.37M 2025-09
Eli Lilly USD 9.79B 6.42B 2025-09
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Halozyme Therapeutics USD 419.66M 357.8M 2025-09
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 2.24B 1.94B 2025-09
MannKind USD 127.39M 70.39M 2025-09
Minerva Neurosciences USD 12.29M 2.96M 2025-09
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Pfizer USD 1.34B 295M 2025-09
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
United Therapeutics USD 1.34B 253M 2025-09
Vanda Pharmaceuticals USD 70.02M 10.96M 2025-09


Halozyme Therapeutics Nakit Ve Eşdeğer - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Feb 2026.